Annals of Surgery · Nov 17, 2026

Prospective Evidence of Concomitant Pancreatic Ductal Adenocarcinoma Risk Among Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms Without Worrisome Features/High-risk Stigmata at Baseline

By Ideno N, Nakamura M, Kin T et al.

Objective: To evaluate the natural history, especially concomitant pancreatic ductal adenocarcinoma (cPDAC) risk in patients with branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) without worrisome features (WF) or high-risk stigmata (HRS). Summary Background Data: BD-IPMNs without WF/HRS are considered low-risk, yet optimal surveillance strategies remain uncertain. Methods: In a prospective multicenter Japan Pancreas Society registry, 1234 patients with BD-IPMN without WF/HRS underwent imaging and laboratory surveillance every 6 months for up to 5.17 years. Cumulative incidence, standardized incidence ratios (SIRs), and competing-risk analyses were performed to assess advanced pancreatic neoplasia, defined as IPMN high-grade dysplasia (IPMN-HGD), invasive IPMN, or cPDAC, and associated risk factors. Outcomes were also evaluated under simulated guideline-recommended extended surveillance intervals. Results: During 5.17 years of follow-up, advanced pancreatic neoplasia developed in 26 patients: 10 IPMN-HGD/invasive IPMN and 16 cPDAC. The 5.17-year cumulative incidence was 2.48%; SIRs relative to the general population were 8.01 overall, 3.07 for IPMN-HGD/invasive IPMN, and 4.91 for cPDAC. The cPDAC SIRs were 6.21 and 3.02 for cysts <20 mm and ≥20 mm, respectively. Diabetes history and mural nodule development predicted IPMN-HGD/invasive IPMN, whereas CA19-9 elevation and new or worsening diabetes predicted cPDAC. Of 19 patients eligible for surveillance interval extension, 13 (68%) had a later simulated detection date. Conclusion: Patients with BD-IPMN without WF/HRS at baseline had 3.07 and 4.91 times the incidences of IPMN-HGD/invasive IPMN and cPDAC expected in the general population, respectively. Surveillance based solely on cyst stability may warrant caution regarding the timely detection of surgically resectable pancreatic cancer.

doi.org/10.1097/sla.0000000000007255PubMed 43040604Populations

AgingResearch.News